nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CA5B—coronary artery disease	0.277	0.819	CbGaD
Methazolamide—CYP2C19—coronary artery disease	0.0612	0.181	CbGaD
Methazolamide—CA14—Furosemide—coronary artery disease	0.0293	0.0655	CbGbCtD
Methazolamide—CA5A—Furosemide—coronary artery disease	0.0278	0.0622	CbGbCtD
Methazolamide—CA6—Furosemide—coronary artery disease	0.0278	0.0622	CbGbCtD
Methazolamide—CA7—Furosemide—coronary artery disease	0.0242	0.0543	CbGbCtD
Methazolamide—CA5B—Furosemide—coronary artery disease	0.0242	0.0543	CbGbCtD
Methazolamide—CA9—Furosemide—coronary artery disease	0.0208	0.0466	CbGbCtD
Methazolamide—CA12—Furosemide—coronary artery disease	0.0208	0.0466	CbGbCtD
Methazolamide—CA1—Furosemide—coronary artery disease	0.0194	0.0436	CbGbCtD
Methazolamide—CA4—Furosemide—coronary artery disease	0.0183	0.041	CbGbCtD
Methazolamide—CA2—Furosemide—coronary artery disease	0.0168	0.0376	CbGbCtD
Methazolamide—CA5B—cervicothoracic ganglion—coronary artery disease	0.0123	0.357	CbGeAlD
Methazolamide—SLC22A6—Enalapril—coronary artery disease	0.0107	0.0241	CbGbCtD
Methazolamide—CYP2C9—Fenofibrate—coronary artery disease	0.00859	0.0192	CbGbCtD
Methazolamide—CYP2C19—Gemfibrozil—coronary artery disease	0.00826	0.0185	CbGbCtD
Methazolamide—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.00814	0.0182	CbGbCtD
Methazolamide—SLC22A6—Captopril—coronary artery disease	0.00804	0.018	CbGbCtD
Methazolamide—CA5B—sinoatrial node—coronary artery disease	0.00796	0.23	CbGeAlD
Methazolamide—SLC22A6—Pravastatin—coronary artery disease	0.0076	0.017	CbGbCtD
Methazolamide—CYP2C19—Clopidogrel—coronary artery disease	0.00716	0.016	CbGbCtD
Methazolamide—CYP2C9—Gemfibrozil—coronary artery disease	0.00687	0.0154	CbGbCtD
Methazolamide—SLC22A6—Furosemide—coronary artery disease	0.00646	0.0145	CbGbCtD
Methazolamide—SLC22A6—Losartan—coronary artery disease	0.00633	0.0142	CbGbCtD
Methazolamide—CYP2C19—Telmisartan—coronary artery disease	0.00626	0.014	CbGbCtD
Methazolamide—CYP2C9—Clopidogrel—coronary artery disease	0.00595	0.0133	CbGbCtD
Methazolamide—CYP3A4—Ticagrelor—coronary artery disease	0.0056	0.0126	CbGbCtD
Methazolamide—CYP2C9—Pitavastatin—coronary artery disease	0.0052	0.0117	CbGbCtD
Methazolamide—CYP2C9—Valsartan—coronary artery disease	0.00506	0.0113	CbGbCtD
Methazolamide—CYP2C19—Timolol—coronary artery disease	0.00505	0.0113	CbGbCtD
Methazolamide—CYP3A4—Fenofibrate—coronary artery disease	0.00499	0.0112	CbGbCtD
Methazolamide—CYP2C19—Rosuvastatin—coronary artery disease	0.00461	0.0103	CbGbCtD
Methazolamide—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.0045	0.0101	CbGbCtD
Methazolamide—CYP2C19—Simvastatin—coronary artery disease	0.00429	0.00961	CbGbCtD
Methazolamide—CYP2C19—Lovastatin—coronary artery disease	0.0042	0.00941	CbGbCtD
Methazolamide—CYP2D6—Niacin—coronary artery disease	0.00413	0.00924	CbGbCtD
Methazolamide—CYP2C9—cardial valve—coronary artery disease	0.00406	0.117	CbGeAlD
Methazolamide—CYP3A4—Gemfibrozil—coronary artery disease	0.00399	0.00895	CbGbCtD
Methazolamide—CYP2C9—Rosuvastatin—coronary artery disease	0.00384	0.0086	CbGbCtD
Methazolamide—CYP2D6—Timolol—coronary artery disease	0.00384	0.00859	CbGbCtD
Methazolamide—CYP2C19—Atorvastatin—coronary artery disease	0.00382	0.00857	CbGbCtD
Methazolamide—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00374	0.00838	CbGbCtD
Methazolamide—CYP2C9—Simvastatin—coronary artery disease	0.00357	0.00799	CbGbCtD
Methazolamide—CYP2C19—Losartan—coronary artery disease	0.0035	0.00784	CbGbCtD
Methazolamide—CYP2C9—Pravastatin—coronary artery disease	0.00349	0.00782	CbGbCtD
Methazolamide—CYP2C9—Lovastatin—coronary artery disease	0.00349	0.00782	CbGbCtD
Methazolamide—CYP3A4—Clopidogrel—coronary artery disease	0.00346	0.00776	CbGbCtD
Methazolamide—CYP2D6—Captopril—coronary artery disease	0.00338	0.00757	CbGbCtD
Methazolamide—CYP2D6—Simvastatin—coronary artery disease	0.00326	0.00731	CbGbCtD
Methazolamide—CYP3A4—Eplerenone—coronary artery disease	0.00322	0.00721	CbGbCtD
Methazolamide—CYP2D6—Pravastatin—coronary artery disease	0.00319	0.00715	CbGbCtD
Methazolamide—CYP2D6—Lovastatin—coronary artery disease	0.00319	0.00715	CbGbCtD
Methazolamide—CYP2C9—Atorvastatin—coronary artery disease	0.00318	0.00712	CbGbCtD
Methazolamide—CYP2C9—Losartan—coronary artery disease	0.00291	0.00651	CbGbCtD
Methazolamide—CYP2D6—Atorvastatin—coronary artery disease	0.00291	0.00651	CbGbCtD
Methazolamide—CYP3A4—Enalapril—coronary artery disease	0.00287	0.00643	CbGbCtD
Methazolamide—Acetazolamide—CA5B—coronary artery disease	0.00282	1	CrCbGaD
Methazolamide—CYP3A4—Ezetimibe—coronary artery disease	0.00223	0.005	CbGbCtD
Methazolamide—CYP3A4—Rosuvastatin—coronary artery disease	0.00223	0.005	CbGbCtD
Methazolamide—CYP3A4—Simvastatin—coronary artery disease	0.00207	0.00465	CbGbCtD
Methazolamide—CYP3A4—Lovastatin—coronary artery disease	0.00203	0.00455	CbGbCtD
Methazolamide—CYP3A4—Pravastatin—coronary artery disease	0.00203	0.00455	CbGbCtD
Methazolamide—CYP3A4—Atorvastatin—coronary artery disease	0.00185	0.00414	CbGbCtD
Methazolamide—CYP3A4—Losartan—coronary artery disease	0.00169	0.00379	CbGbCtD
Methazolamide—CA14—cardiac ventricle—coronary artery disease	0.00101	0.0292	CbGeAlD
Methazolamide—CA14—heart—coronary artery disease	0.000663	0.0192	CbGeAlD
Methazolamide—CA14—cardiac atrium—coronary artery disease	0.000567	0.0164	CbGeAlD
Methazolamide—CA4—cardiac ventricle—coronary artery disease	0.000488	0.0141	CbGeAlD
Methazolamide—CA5B—heart—coronary artery disease	0.000464	0.0134	CbGeAlD
Methazolamide—CA4—myocardium—coronary artery disease	0.000459	0.0133	CbGeAlD
Methazolamide—CA5B—cardiovascular system—coronary artery disease	0.000438	0.0127	CbGeAlD
Methazolamide—CA1—heart—coronary artery disease	0.00041	0.0118	CbGeAlD
Methazolamide—CA2—cardiac ventricle—coronary artery disease	0.000404	0.0117	CbGeAlD
Methazolamide—CA5B—cardiac atrium—coronary artery disease	0.000397	0.0115	CbGeAlD
Methazolamide—CA1—cardiovascular system—coronary artery disease	0.000387	0.0112	CbGeAlD
Methazolamide—CA2—myocardium—coronary artery disease	0.00038	0.011	CbGeAlD
Methazolamide—CA5B—blood—coronary artery disease	0.000346	0.01	CbGeAlD
Methazolamide—CA4—heart—coronary artery disease	0.00032	0.00925	CbGeAlD
Methazolamide—CA1—blood—coronary artery disease	0.000306	0.00883	CbGeAlD
Methazolamide—CA4—cardiovascular system—coronary artery disease	0.000302	0.00873	CbGeAlD
Methazolamide—CA4—cardiac atrium—coronary artery disease	0.000274	0.00791	CbGeAlD
Methazolamide—CA2—heart—coronary artery disease	0.000265	0.00767	CbGeAlD
Methazolamide—CA2—cardiovascular system—coronary artery disease	0.00025	0.00724	CbGeAlD
Methazolamide—CA4—blood—coronary artery disease	0.000239	0.00691	CbGeAlD
Methazolamide—CA2—cardiac atrium—coronary artery disease	0.000227	0.00656	CbGeAlD
Methazolamide—CYP2C9—heart—coronary artery disease	0.000225	0.00649	CbGeAlD
Methazolamide—CYP2C19—blood—coronary artery disease	0.000216	0.00625	CbGeAlD
Methazolamide—CYP2C9—cardiovascular system—coronary artery disease	0.000212	0.00613	CbGeAlD
Methazolamide—CYP2E1—cardiovascular system—coronary artery disease	0.000201	0.00581	CbGeAlD
Methazolamide—CA2—blood—coronary artery disease	0.000198	0.00573	CbGeAlD
Methazolamide—CYP2C9—blood—coronary artery disease	0.000168	0.00484	CbGeAlD
Methazolamide—CYP2E1—blood—coronary artery disease	0.000159	0.00459	CbGeAlD
Methazolamide—CYP3A4—blood—coronary artery disease	0.000128	0.00369	CbGeAlD
Methazolamide—CYP2D6—blood—coronary artery disease	0.000126	0.00364	CbGeAlD
Methazolamide—Anaphylactic shock—Losartan—coronary artery disease	0.000101	0.000941	CcSEcCtD
Methazolamide—Decreased appetite—Trandolapril—coronary artery disease	0.000101	0.00094	CcSEcCtD
Methazolamide—Decreased appetite—Enalapril—coronary artery disease	0.0001	0.000936	CcSEcCtD
Methazolamide—Dyspepsia—Telmisartan—coronary artery disease	0.0001	0.000935	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.0001	0.000934	CcSEcCtD
Methazolamide—Fatigue—Trandolapril—coronary artery disease	9.98e-05	0.000932	CcSEcCtD
Methazolamide—Anorexia—Furosemide—coronary artery disease	9.95e-05	0.000929	CcSEcCtD
Methazolamide—Fatigue—Enalapril—coronary artery disease	9.94e-05	0.000929	CcSEcCtD
Methazolamide—Paraesthesia—Captopril—coronary artery disease	9.93e-05	0.000928	CcSEcCtD
Methazolamide—Asthenia—Ezetimibe—coronary artery disease	9.92e-05	0.000927	CcSEcCtD
Methazolamide—Urticaria—Valsartan—coronary artery disease	9.9e-05	0.000924	CcSEcCtD
Methazolamide—Decreased appetite—Telmisartan—coronary artery disease	9.89e-05	0.000924	CcSEcCtD
Methazolamide—Nausea—Rosuvastatin—coronary artery disease	9.88e-05	0.000923	CcSEcCtD
Methazolamide—Diarrhoea—Fenofibrate—coronary artery disease	9.88e-05	0.000923	CcSEcCtD
Methazolamide—Urticaria—Olmesartan—coronary artery disease	9.85e-05	0.00092	CcSEcCtD
Methazolamide—Somnolence—Captopril—coronary artery disease	9.83e-05	0.000918	CcSEcCtD
Methazolamide—Feeling abnormal—Pravastatin—coronary artery disease	9.83e-05	0.000918	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Telmisartan—coronary artery disease	9.82e-05	0.000917	CcSEcCtD
Methazolamide—Ill-defined disorder—Ramipril—coronary artery disease	9.82e-05	0.000917	CcSEcCtD
Methazolamide—Fatigue—Telmisartan—coronary artery disease	9.81e-05	0.000916	CcSEcCtD
Methazolamide—Body temperature increased—Olmesartan—coronary artery disease	9.8e-05	0.000915	CcSEcCtD
Methazolamide—Dyspepsia—Captopril—coronary artery disease	9.74e-05	0.000909	CcSEcCtD
Methazolamide—Diarrhoea—Clopidogrel—coronary artery disease	9.71e-05	0.000907	CcSEcCtD
Methazolamide—Asthenia—Eplerenone—coronary artery disease	9.71e-05	0.000907	CcSEcCtD
Methazolamide—Diarrhoea—Lovastatin—coronary artery disease	9.65e-05	0.000901	CcSEcCtD
Methazolamide—Paraesthesia—Perindopril—coronary artery disease	9.64e-05	0.000901	CcSEcCtD
Methazolamide—Urticaria—Niacin—coronary artery disease	9.62e-05	0.000899	CcSEcCtD
Methazolamide—Decreased appetite—Captopril—coronary artery disease	9.62e-05	0.000898	CcSEcCtD
Methazolamide—Anorexia—Losartan—coronary artery disease	9.6e-05	0.000897	CcSEcCtD
Methazolamide—Nausea—Acetylsalicylic acid—coronary artery disease	9.6e-05	0.000897	CcSEcCtD
Methazolamide—Body temperature increased—Niacin—coronary artery disease	9.57e-05	0.000894	CcSEcCtD
Methazolamide—Somnolence—Perindopril—coronary artery disease	9.55e-05	0.000892	CcSEcCtD
Methazolamide—Malaise—Ramipril—coronary artery disease	9.54e-05	0.000891	CcSEcCtD
Methazolamide—Feeling abnormal—Trandolapril—coronary artery disease	9.54e-05	0.000891	CcSEcCtD
Methazolamide—Fatigue—Captopril—coronary artery disease	9.54e-05	0.000891	CcSEcCtD
Methazolamide—Vertigo—Ramipril—coronary artery disease	9.51e-05	0.000888	CcSEcCtD
Methazolamide—Feeling abnormal—Enalapril—coronary artery disease	9.5e-05	0.000888	CcSEcCtD
Methazolamide—Leukopenia—Ramipril—coronary artery disease	9.47e-05	0.000885	CcSEcCtD
Methazolamide—Urticaria—Pravastatin—coronary artery disease	9.47e-05	0.000885	CcSEcCtD
Methazolamide—Asthenia—Simvastatin—coronary artery disease	9.46e-05	0.000884	CcSEcCtD
Methazolamide—Diarrhoea—Ezetimibe—coronary artery disease	9.46e-05	0.000884	CcSEcCtD
Methazolamide—Dyspepsia—Perindopril—coronary artery disease	9.45e-05	0.000883	CcSEcCtD
Methazolamide—Body temperature increased—Pravastatin—coronary artery disease	9.43e-05	0.00088	CcSEcCtD
Methazolamide—Dysgeusia—Lisinopril—coronary artery disease	9.4e-05	0.000878	CcSEcCtD
Methazolamide—Paraesthesia—Furosemide—coronary artery disease	9.38e-05	0.000876	CcSEcCtD
Methazolamide—Feeling abnormal—Telmisartan—coronary artery disease	9.37e-05	0.000876	CcSEcCtD
Methazolamide—Decreased appetite—Perindopril—coronary artery disease	9.34e-05	0.000872	CcSEcCtD
Methazolamide—Vertigo—Timolol—coronary artery disease	9.3e-05	0.000868	CcSEcCtD
Methazolamide—Somnolence—Furosemide—coronary artery disease	9.28e-05	0.000867	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Perindopril—coronary artery disease	9.27e-05	0.000866	CcSEcCtD
Methazolamide—Diarrhoea—Eplerenone—coronary artery disease	9.26e-05	0.000865	CcSEcCtD
Methazolamide—Fatigue—Perindopril—coronary artery disease	9.26e-05	0.000865	CcSEcCtD
Methazolamide—Urticaria—Trandolapril—coronary artery disease	9.2e-05	0.000859	CcSEcCtD
Methazolamide—Vomiting—Fenofibrate—coronary artery disease	9.18e-05	0.000858	CcSEcCtD
Methazolamide—Convulsion—Ramipril—coronary artery disease	9.17e-05	0.000856	CcSEcCtD
Methazolamide—Urticaria—Enalapril—coronary artery disease	9.16e-05	0.000856	CcSEcCtD
Methazolamide—Body temperature increased—Trandolapril—coronary artery disease	9.15e-05	0.000855	CcSEcCtD
Methazolamide—Body temperature increased—Enalapril—coronary artery disease	9.12e-05	0.000852	CcSEcCtD
Methazolamide—Feeling abnormal—Captopril—coronary artery disease	9.12e-05	0.000851	CcSEcCtD
Methazolamide—Rash—Fenofibrate—coronary artery disease	9.11e-05	0.00085	CcSEcCtD
Methazolamide—Dermatitis—Fenofibrate—coronary artery disease	9.1e-05	0.00085	CcSEcCtD
Methazolamide—Decreased appetite—Furosemide—coronary artery disease	9.08e-05	0.000848	CcSEcCtD
Methazolamide—Headache—Fenofibrate—coronary artery disease	9.05e-05	0.000845	CcSEcCtD
Methazolamide—Paraesthesia—Losartan—coronary artery disease	9.05e-05	0.000845	CcSEcCtD
Methazolamide—Urticaria—Telmisartan—coronary artery disease	9.04e-05	0.000844	CcSEcCtD
Methazolamide—Vomiting—Clopidogrel—coronary artery disease	9.03e-05	0.000843	CcSEcCtD
Methazolamide—Diarrhoea—Simvastatin—coronary artery disease	9.02e-05	0.000843	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Furosemide—coronary artery disease	9.01e-05	0.000842	CcSEcCtD
Methazolamide—Fatigue—Furosemide—coronary artery disease	9e-05	0.000841	CcSEcCtD
Methazolamide—Body temperature increased—Telmisartan—coronary artery disease	8.99e-05	0.00084	CcSEcCtD
Methazolamide—Vomiting—Lovastatin—coronary artery disease	8.97e-05	0.000837	CcSEcCtD
Methazolamide—Somnolence—Losartan—coronary artery disease	8.96e-05	0.000836	CcSEcCtD
Methazolamide—Rash—Clopidogrel—coronary artery disease	8.95e-05	0.000836	CcSEcCtD
Methazolamide—Dermatitis—Clopidogrel—coronary artery disease	8.94e-05	0.000835	CcSEcCtD
Methazolamide—Asthenia—Valsartan—coronary artery disease	8.94e-05	0.000835	CcSEcCtD
Methazolamide—Ill-defined disorder—Lisinopril—coronary artery disease	8.91e-05	0.000832	CcSEcCtD
Methazolamide—Discomfort—Ramipril—coronary artery disease	8.9e-05	0.000831	CcSEcCtD
Methazolamide—Asthenia—Olmesartan—coronary artery disease	8.89e-05	0.000831	CcSEcCtD
Methazolamide—Headache—Clopidogrel—coronary artery disease	8.89e-05	0.000831	CcSEcCtD
Methazolamide—Rash—Lovastatin—coronary artery disease	8.89e-05	0.00083	CcSEcCtD
Methazolamide—Dermatitis—Lovastatin—coronary artery disease	8.88e-05	0.00083	CcSEcCtD
Methazolamide—Dyspepsia—Losartan—coronary artery disease	8.87e-05	0.000828	CcSEcCtD
Methazolamide—Feeling abnormal—Perindopril—coronary artery disease	8.85e-05	0.000827	CcSEcCtD
Methazolamide—Headache—Lovastatin—coronary artery disease	8.83e-05	0.000825	CcSEcCtD
Methazolamide—Vomiting—Ezetimibe—coronary artery disease	8.79e-05	0.000821	CcSEcCtD
Methazolamide—Decreased appetite—Losartan—coronary artery disease	8.76e-05	0.000818	CcSEcCtD
Methazolamide—Body temperature increased—Captopril—coronary artery disease	8.74e-05	0.000817	CcSEcCtD
Methazolamide—Rash—Ezetimibe—coronary artery disease	8.72e-05	0.000814	CcSEcCtD
Methazolamide—Dermatitis—Ezetimibe—coronary artery disease	8.71e-05	0.000814	CcSEcCtD
Methazolamide—Confusional state—Ramipril—coronary artery disease	8.71e-05	0.000813	CcSEcCtD
Methazolamide—Discomfort—Timolol—coronary artery disease	8.7e-05	0.000813	CcSEcCtD
Methazolamide—Asthenia—Niacin—coronary artery disease	8.69e-05	0.000812	CcSEcCtD
Methazolamide—Fatigue—Losartan—coronary artery disease	8.69e-05	0.000811	CcSEcCtD
Methazolamide—Headache—Ezetimibe—coronary artery disease	8.66e-05	0.000809	CcSEcCtD
Methazolamide—Malaise—Lisinopril—coronary artery disease	8.66e-05	0.000808	CcSEcCtD
Methazolamide—Anaphylactic shock—Ramipril—coronary artery disease	8.64e-05	0.000807	CcSEcCtD
Methazolamide—Vertigo—Lisinopril—coronary artery disease	8.62e-05	0.000805	CcSEcCtD
Methazolamide—Vomiting—Eplerenone—coronary artery disease	8.61e-05	0.000804	CcSEcCtD
Methazolamide—Feeling abnormal—Furosemide—coronary artery disease	8.6e-05	0.000804	CcSEcCtD
Methazolamide—Leukopenia—Lisinopril—coronary artery disease	8.59e-05	0.000802	CcSEcCtD
Methazolamide—Nausea—Fenofibrate—coronary artery disease	8.58e-05	0.000801	CcSEcCtD
Methazolamide—Asthenia—Pravastatin—coronary artery disease	8.56e-05	0.000799	CcSEcCtD
Methazolamide—Rash—Eplerenone—coronary artery disease	8.54e-05	0.000797	CcSEcCtD
Methazolamide—Urticaria—Perindopril—coronary artery disease	8.53e-05	0.000797	CcSEcCtD
Methazolamide—Dermatitis—Eplerenone—coronary artery disease	8.53e-05	0.000796	CcSEcCtD
Methazolamide—Diarrhoea—Valsartan—coronary artery disease	8.52e-05	0.000796	CcSEcCtD
Methazolamide—Confusional state—Timolol—coronary artery disease	8.51e-05	0.000795	CcSEcCtD
Methazolamide—Body temperature increased—Perindopril—coronary artery disease	8.49e-05	0.000793	CcSEcCtD
Methazolamide—Diarrhoea—Olmesartan—coronary artery disease	8.48e-05	0.000792	CcSEcCtD
Methazolamide—Headache—Eplerenone—coronary artery disease	8.48e-05	0.000792	CcSEcCtD
Methazolamide—Anaphylactic shock—Timolol—coronary artery disease	8.44e-05	0.000789	CcSEcCtD
Methazolamide—Nausea—Clopidogrel—coronary artery disease	8.43e-05	0.000788	CcSEcCtD
Methazolamide—Vomiting—Simvastatin—coronary artery disease	8.39e-05	0.000783	CcSEcCtD
Methazolamide—Nausea—Lovastatin—coronary artery disease	8.38e-05	0.000782	CcSEcCtD
Methazolamide—Rash—Simvastatin—coronary artery disease	8.32e-05	0.000777	CcSEcCtD
Methazolamide—Dermatitis—Simvastatin—coronary artery disease	8.31e-05	0.000776	CcSEcCtD
Methazolamide—Asthenia—Trandolapril—coronary artery disease	8.31e-05	0.000776	CcSEcCtD
Methazolamide—Feeling abnormal—Losartan—coronary artery disease	8.3e-05	0.000775	CcSEcCtD
Methazolamide—Urticaria—Furosemide—coronary artery disease	8.29e-05	0.000775	CcSEcCtD
Methazolamide—Diarrhoea—Niacin—coronary artery disease	8.29e-05	0.000774	CcSEcCtD
Methazolamide—Asthenia—Enalapril—coronary artery disease	8.28e-05	0.000773	CcSEcCtD
Methazolamide—Headache—Simvastatin—coronary artery disease	8.26e-05	0.000772	CcSEcCtD
Methazolamide—Body temperature increased—Furosemide—coronary artery disease	8.25e-05	0.000771	CcSEcCtD
Methazolamide—Anorexia—Ramipril—coronary artery disease	8.23e-05	0.000769	CcSEcCtD
Methazolamide—Nausea—Ezetimibe—coronary artery disease	8.22e-05	0.000767	CcSEcCtD
Methazolamide—Asthenia—Telmisartan—coronary artery disease	8.16e-05	0.000762	CcSEcCtD
Methazolamide—Diarrhoea—Pravastatin—coronary artery disease	8.16e-05	0.000762	CcSEcCtD
Methazolamide—Discomfort—Lisinopril—coronary artery disease	8.07e-05	0.000754	CcSEcCtD
Methazolamide—Anorexia—Timolol—coronary artery disease	8.05e-05	0.000752	CcSEcCtD
Methazolamide—Nausea—Eplerenone—coronary artery disease	8.04e-05	0.000751	CcSEcCtD
Methazolamide—Urticaria—Losartan—coronary artery disease	8e-05	0.000747	CcSEcCtD
Methazolamide—Body temperature increased—Losartan—coronary artery disease	7.96e-05	0.000744	CcSEcCtD
Methazolamide—Asthenia—Captopril—coronary artery disease	7.94e-05	0.000741	CcSEcCtD
Methazolamide—Diarrhoea—Trandolapril—coronary artery disease	7.92e-05	0.00074	CcSEcCtD
Methazolamide—Vomiting—Valsartan—coronary artery disease	7.92e-05	0.00074	CcSEcCtD
Methazolamide—Confusional state—Lisinopril—coronary artery disease	7.9e-05	0.000738	CcSEcCtD
Methazolamide—Diarrhoea—Enalapril—coronary artery disease	7.89e-05	0.000737	CcSEcCtD
Methazolamide—Vomiting—Olmesartan—coronary artery disease	7.88e-05	0.000736	CcSEcCtD
Methazolamide—Rash—Valsartan—coronary artery disease	7.85e-05	0.000733	CcSEcCtD
Methazolamide—Dermatitis—Valsartan—coronary artery disease	7.85e-05	0.000733	CcSEcCtD
Methazolamide—Nausea—Simvastatin—coronary artery disease	7.83e-05	0.000732	CcSEcCtD
Methazolamide—Anaphylactic shock—Lisinopril—coronary artery disease	7.83e-05	0.000732	CcSEcCtD
Methazolamide—Rash—Olmesartan—coronary artery disease	7.82e-05	0.00073	CcSEcCtD
Methazolamide—Dermatitis—Olmesartan—coronary artery disease	7.81e-05	0.000729	CcSEcCtD
Methazolamide—Headache—Valsartan—coronary artery disease	7.8e-05	0.000729	CcSEcCtD
Methazolamide—Diarrhoea—Telmisartan—coronary artery disease	7.78e-05	0.000727	CcSEcCtD
Methazolamide—Headache—Olmesartan—coronary artery disease	7.77e-05	0.000725	CcSEcCtD
Methazolamide—Paraesthesia—Ramipril—coronary artery disease	7.76e-05	0.000724	CcSEcCtD
Methazolamide—Asthenia—Perindopril—coronary artery disease	7.71e-05	0.00072	CcSEcCtD
Methazolamide—Vomiting—Niacin—coronary artery disease	7.7e-05	0.000719	CcSEcCtD
Methazolamide—Somnolence—Ramipril—coronary artery disease	7.68e-05	0.000717	CcSEcCtD
Methazolamide—Rash—Niacin—coronary artery disease	7.64e-05	0.000713	CcSEcCtD
Methazolamide—Dermatitis—Niacin—coronary artery disease	7.63e-05	0.000713	CcSEcCtD
Methazolamide—Dyspepsia—Ramipril—coronary artery disease	7.6e-05	0.00071	CcSEcCtD
Methazolamide—Headache—Niacin—coronary artery disease	7.59e-05	0.000709	CcSEcCtD
Methazolamide—Paraesthesia—Timolol—coronary artery disease	7.58e-05	0.000708	CcSEcCtD
Methazolamide—Vomiting—Pravastatin—coronary artery disease	7.58e-05	0.000708	CcSEcCtD
Methazolamide—Diarrhoea—Captopril—coronary artery disease	7.57e-05	0.000707	CcSEcCtD
Methazolamide—Rash—Pravastatin—coronary artery disease	7.52e-05	0.000702	CcSEcCtD
Methazolamide—Dermatitis—Pravastatin—coronary artery disease	7.51e-05	0.000702	CcSEcCtD
Methazolamide—Decreased appetite—Ramipril—coronary artery disease	7.51e-05	0.000701	CcSEcCtD
Methazolamide—Somnolence—Timolol—coronary artery disease	7.51e-05	0.000701	CcSEcCtD
Methazolamide—Asthenia—Furosemide—coronary artery disease	7.49e-05	0.0007	CcSEcCtD
Methazolamide—Headache—Pravastatin—coronary artery disease	7.47e-05	0.000698	CcSEcCtD
Methazolamide—Anorexia—Lisinopril—coronary artery disease	7.47e-05	0.000697	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Ramipril—coronary artery disease	7.46e-05	0.000696	CcSEcCtD
Methazolamide—Fatigue—Ramipril—coronary artery disease	7.45e-05	0.000696	CcSEcCtD
Methazolamide—Dyspepsia—Timolol—coronary artery disease	7.43e-05	0.000694	CcSEcCtD
Methazolamide—Nausea—Valsartan—coronary artery disease	7.4e-05	0.000691	CcSEcCtD
Methazolamide—Nausea—Olmesartan—coronary artery disease	7.36e-05	0.000688	CcSEcCtD
Methazolamide—Vomiting—Trandolapril—coronary artery disease	7.36e-05	0.000688	CcSEcCtD
Methazolamide—Diarrhoea—Perindopril—coronary artery disease	7.35e-05	0.000686	CcSEcCtD
Methazolamide—Decreased appetite—Timolol—coronary artery disease	7.34e-05	0.000686	CcSEcCtD
Methazolamide—Vomiting—Enalapril—coronary artery disease	7.33e-05	0.000685	CcSEcCtD
Methazolamide—Rash—Trandolapril—coronary artery disease	7.3e-05	0.000682	CcSEcCtD
Methazolamide—Dermatitis—Trandolapril—coronary artery disease	7.29e-05	0.000681	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Timolol—coronary artery disease	7.29e-05	0.000681	CcSEcCtD
Methazolamide—Fatigue—Timolol—coronary artery disease	7.28e-05	0.00068	CcSEcCtD
Methazolamide—Rash—Enalapril—coronary artery disease	7.27e-05	0.000679	CcSEcCtD
Methazolamide—Dermatitis—Enalapril—coronary artery disease	7.27e-05	0.000679	CcSEcCtD
Methazolamide—Headache—Trandolapril—coronary artery disease	7.25e-05	0.000678	CcSEcCtD
Methazolamide—Vomiting—Telmisartan—coronary artery disease	7.23e-05	0.000676	CcSEcCtD
Methazolamide—Asthenia—Losartan—coronary artery disease	7.23e-05	0.000675	CcSEcCtD
Methazolamide—Headache—Enalapril—coronary artery disease	7.23e-05	0.000675	CcSEcCtD
Methazolamide—Nausea—Niacin—coronary artery disease	7.19e-05	0.000672	CcSEcCtD
Methazolamide—Rash—Telmisartan—coronary artery disease	7.17e-05	0.00067	CcSEcCtD
Methazolamide—Dermatitis—Telmisartan—coronary artery disease	7.17e-05	0.000669	CcSEcCtD
Methazolamide—Diarrhoea—Furosemide—coronary artery disease	7.14e-05	0.000667	CcSEcCtD
Methazolamide—Headache—Telmisartan—coronary artery disease	7.13e-05	0.000666	CcSEcCtD
Methazolamide—Feeling abnormal—Ramipril—coronary artery disease	7.12e-05	0.000665	CcSEcCtD
Methazolamide—Nausea—Pravastatin—coronary artery disease	7.08e-05	0.000662	CcSEcCtD
Methazolamide—Paraesthesia—Lisinopril—coronary artery disease	7.03e-05	0.000657	CcSEcCtD
Methazolamide—Vomiting—Captopril—coronary artery disease	7.03e-05	0.000657	CcSEcCtD
Methazolamide—Rash—Captopril—coronary artery disease	6.97e-05	0.000651	CcSEcCtD
Methazolamide—Dermatitis—Captopril—coronary artery disease	6.97e-05	0.000651	CcSEcCtD
Methazolamide—Somnolence—Lisinopril—coronary artery disease	6.96e-05	0.00065	CcSEcCtD
Methazolamide—Feeling abnormal—Timolol—coronary artery disease	6.96e-05	0.00065	CcSEcCtD
Methazolamide—Headache—Captopril—coronary artery disease	6.93e-05	0.000647	CcSEcCtD
Methazolamide—Dyspepsia—Lisinopril—coronary artery disease	6.9e-05	0.000644	CcSEcCtD
Methazolamide—Diarrhoea—Losartan—coronary artery disease	6.89e-05	0.000644	CcSEcCtD
Methazolamide—Nausea—Trandolapril—coronary artery disease	6.88e-05	0.000642	CcSEcCtD
Methazolamide—Urticaria—Ramipril—coronary artery disease	6.86e-05	0.000641	CcSEcCtD
Methazolamide—Nausea—Enalapril—coronary artery disease	6.85e-05	0.00064	CcSEcCtD
Methazolamide—Vomiting—Perindopril—coronary artery disease	6.83e-05	0.000638	CcSEcCtD
Methazolamide—Body temperature increased—Ramipril—coronary artery disease	6.83e-05	0.000638	CcSEcCtD
Methazolamide—Decreased appetite—Lisinopril—coronary artery disease	6.81e-05	0.000636	CcSEcCtD
Methazolamide—Rash—Perindopril—coronary artery disease	6.77e-05	0.000632	CcSEcCtD
Methazolamide—Dermatitis—Perindopril—coronary artery disease	6.77e-05	0.000632	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Lisinopril—coronary artery disease	6.76e-05	0.000632	CcSEcCtD
Methazolamide—Nausea—Telmisartan—coronary artery disease	6.76e-05	0.000631	CcSEcCtD
Methazolamide—Fatigue—Lisinopril—coronary artery disease	6.75e-05	0.000631	CcSEcCtD
Methazolamide—Headache—Perindopril—coronary artery disease	6.73e-05	0.000628	CcSEcCtD
Methazolamide—Urticaria—Timolol—coronary artery disease	6.71e-05	0.000627	CcSEcCtD
Methazolamide—Body temperature increased—Timolol—coronary artery disease	6.68e-05	0.000623	CcSEcCtD
Methazolamide—Vomiting—Furosemide—coronary artery disease	6.64e-05	0.00062	CcSEcCtD
Methazolamide—Rash—Furosemide—coronary artery disease	6.58e-05	0.000615	CcSEcCtD
Methazolamide—Dermatitis—Furosemide—coronary artery disease	6.58e-05	0.000614	CcSEcCtD
Methazolamide—Nausea—Captopril—coronary artery disease	6.57e-05	0.000614	CcSEcCtD
Methazolamide—Headache—Furosemide—coronary artery disease	6.54e-05	0.000611	CcSEcCtD
Methazolamide—Feeling abnormal—Lisinopril—coronary artery disease	6.46e-05	0.000603	CcSEcCtD
Methazolamide—Vomiting—Losartan—coronary artery disease	6.41e-05	0.000598	CcSEcCtD
Methazolamide—Nausea—Perindopril—coronary artery disease	6.38e-05	0.000596	CcSEcCtD
Methazolamide—Rash—Losartan—coronary artery disease	6.35e-05	0.000593	CcSEcCtD
Methazolamide—Dermatitis—Losartan—coronary artery disease	6.35e-05	0.000593	CcSEcCtD
Methazolamide—Headache—Losartan—coronary artery disease	6.31e-05	0.000589	CcSEcCtD
Methazolamide—Urticaria—Lisinopril—coronary artery disease	6.22e-05	0.000581	CcSEcCtD
Methazolamide—Nausea—Furosemide—coronary artery disease	6.2e-05	0.000579	CcSEcCtD
Methazolamide—Asthenia—Ramipril—coronary artery disease	6.2e-05	0.000579	CcSEcCtD
Methazolamide—Body temperature increased—Lisinopril—coronary artery disease	6.19e-05	0.000578	CcSEcCtD
Methazolamide—Asthenia—Timolol—coronary artery disease	6.06e-05	0.000566	CcSEcCtD
Methazolamide—Nausea—Losartan—coronary artery disease	5.98e-05	0.000559	CcSEcCtD
Methazolamide—Diarrhoea—Ramipril—coronary artery disease	5.91e-05	0.000552	CcSEcCtD
Methazolamide—Diarrhoea—Timolol—coronary artery disease	5.78e-05	0.00054	CcSEcCtD
Methazolamide—Asthenia—Lisinopril—coronary artery disease	5.62e-05	0.000525	CcSEcCtD
Methazolamide—Vomiting—Ramipril—coronary artery disease	5.49e-05	0.000513	CcSEcCtD
Methazolamide—Rash—Ramipril—coronary artery disease	5.45e-05	0.000509	CcSEcCtD
Methazolamide—Dermatitis—Ramipril—coronary artery disease	5.44e-05	0.000508	CcSEcCtD
Methazolamide—Headache—Ramipril—coronary artery disease	5.41e-05	0.000505	CcSEcCtD
Methazolamide—Vomiting—Timolol—coronary artery disease	5.37e-05	0.000501	CcSEcCtD
Methazolamide—Diarrhoea—Lisinopril—coronary artery disease	5.36e-05	0.000501	CcSEcCtD
Methazolamide—Rash—Timolol—coronary artery disease	5.32e-05	0.000497	CcSEcCtD
Methazolamide—Dermatitis—Timolol—coronary artery disease	5.32e-05	0.000497	CcSEcCtD
Methazolamide—Headache—Timolol—coronary artery disease	5.29e-05	0.000494	CcSEcCtD
Methazolamide—Nausea—Ramipril—coronary artery disease	5.13e-05	0.000479	CcSEcCtD
Methazolamide—Nausea—Timolol—coronary artery disease	5.02e-05	0.000468	CcSEcCtD
Methazolamide—Vomiting—Lisinopril—coronary artery disease	4.98e-05	0.000465	CcSEcCtD
Methazolamide—Rash—Lisinopril—coronary artery disease	4.94e-05	0.000461	CcSEcCtD
Methazolamide—Dermatitis—Lisinopril—coronary artery disease	4.93e-05	0.000461	CcSEcCtD
Methazolamide—Headache—Lisinopril—coronary artery disease	4.91e-05	0.000458	CcSEcCtD
Methazolamide—Nausea—Lisinopril—coronary artery disease	4.65e-05	0.000435	CcSEcCtD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	2.9e-06	4.11e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SULT1E1—coronary artery disease	2.9e-06	4.11e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PLCB1—coronary artery disease	2.88e-06	4.08e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	2.87e-06	4.07e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALDH2—coronary artery disease	2.85e-06	4.03e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ABCA1—coronary artery disease	2.79e-06	3.96e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—VCAN—coronary artery disease	2.79e-06	3.95e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.77e-06	3.93e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—LIPC—coronary artery disease	2.77e-06	3.93e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HBA1—coronary artery disease	2.77e-06	3.93e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3C2A—coronary artery disease	2.77e-06	3.93e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALDOA—coronary artery disease	2.77e-06	3.92e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HK2—coronary artery disease	2.77e-06	3.92e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKR1B1—coronary artery disease	2.77e-06	3.92e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—VCAN—coronary artery disease	2.77e-06	3.92e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOC3—coronary artery disease	2.76e-06	3.9e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALDOA—coronary artery disease	2.75e-06	3.89e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—LDLR—coronary artery disease	2.74e-06	3.88e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.74e-06	3.87e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—AKT1—coronary artery disease	2.71e-06	3.83e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GGT1—coronary artery disease	2.71e-06	3.83e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GOT1—coronary artery disease	2.71e-06	3.83e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC9A1—coronary artery disease	2.71e-06	3.83e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTT1—coronary artery disease	2.71e-06	3.83e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—DCN—coronary artery disease	2.69e-06	3.81e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GCLC—coronary artery disease	2.68e-06	3.79e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CETP—coronary artery disease	2.68e-06	3.79e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—DCN—coronary artery disease	2.67e-06	3.78e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC27A1—coronary artery disease	2.66e-06	3.76e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SDC1—coronary artery disease	2.65e-06	3.75e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CA—coronary artery disease	2.64e-06	3.74e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALDH2—coronary artery disease	2.62e-06	3.71e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CPT1B—coronary artery disease	2.6e-06	3.69e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LCAT—coronary artery disease	2.6e-06	3.69e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALDH2—coronary artery disease	2.59e-06	3.67e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOA4—coronary artery disease	2.56e-06	3.62e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—LIPC—coronary artery disease	2.55e-06	3.61e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HBA1—coronary artery disease	2.55e-06	3.61e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP2C19—coronary artery disease	2.55e-06	3.61e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	2.55e-06	3.61e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOC3—coronary artery disease	2.53e-06	3.59e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CA—coronary artery disease	2.53e-06	3.59e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.53e-06	3.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HBA1—coronary artery disease	2.53e-06	3.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—LIPC—coronary artery disease	2.53e-06	3.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2C19—coronary artery disease	2.53e-06	3.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	2.53e-06	3.58e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—LDLR—coronary artery disease	2.52e-06	3.57e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOC3—coronary artery disease	2.51e-06	3.56e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PSMA6—coronary artery disease	2.5e-06	3.54e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PSMB5—coronary artery disease	2.5e-06	3.54e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—LDLR—coronary artery disease	2.5e-06	3.54e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.49e-06	3.53e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.49e-06	3.53e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC9A1—coronary artery disease	2.49e-06	3.52e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTT1—coronary artery disease	2.49e-06	3.52e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PDHA1—coronary artery disease	2.47e-06	3.5e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GCLM—coronary artery disease	2.47e-06	3.5e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTT1—coronary artery disease	2.47e-06	3.49e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC9A1—coronary artery disease	2.47e-06	3.49e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GCLC—coronary artery disease	2.46e-06	3.48e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CETP—coronary artery disease	2.46e-06	3.48e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CTGF—coronary artery disease	2.44e-06	3.46e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GCLC—coronary artery disease	2.44e-06	3.45e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CETP—coronary artery disease	2.44e-06	3.45e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SDC1—coronary artery disease	2.43e-06	3.45e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTP1—coronary artery disease	2.43e-06	3.44e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CA—coronary artery disease	2.43e-06	3.44e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GOT2—coronary artery disease	2.42e-06	3.43e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMGCR—coronary artery disease	2.42e-06	3.43e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SDC1—coronary artery disease	2.41e-06	3.42e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPARGC1A—coronary artery disease	2.41e-06	3.41e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HMOX1—coronary artery disease	2.4e-06	3.4e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TXNRD1—coronary artery disease	2.39e-06	3.39e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP11B2—coronary artery disease	2.39e-06	3.39e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CAT—coronary artery disease	2.37e-06	3.35e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC22A3—coronary artery disease	2.35e-06	3.33e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ARNTL—coronary artery disease	2.32e-06	3.29e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HADH—coronary artery disease	2.32e-06	3.29e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PSMB5—coronary artery disease	2.3e-06	3.25e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PSMA6—coronary artery disease	2.3e-06	3.25e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APOB—coronary artery disease	2.3e-06	3.25e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PSMA6—coronary artery disease	2.28e-06	3.23e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PSMB5—coronary artery disease	2.28e-06	3.23e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.27e-06	3.22e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CTGF—coronary artery disease	2.25e-06	3.18e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTM1—coronary artery disease	2.23e-06	3.16e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CTGF—coronary artery disease	2.23e-06	3.15e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMGCR—coronary artery disease	2.23e-06	3.15e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GOT2—coronary artery disease	2.23e-06	3.15e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PLCB1—coronary artery disease	2.22e-06	3.15e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMGCR—coronary artery disease	2.21e-06	3.12e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GOT2—coronary artery disease	2.21e-06	3.12e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOA2—coronary artery disease	2.2e-06	3.12e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPX2—coronary artery disease	2.2e-06	3.12e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.2e-06	3.12e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—LPL—coronary artery disease	2.19e-06	3.11e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.18e-06	3.09e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPX4—coronary artery disease	2.17e-06	3.08e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HK1—coronary artery disease	2.17e-06	3.08e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.17e-06	3.08e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.17e-06	3.08e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—AKT1—coronary artery disease	2.16e-06	3.06e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCA1—coronary artery disease	2.16e-06	3.05e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HADHA—coronary artery disease	2.15e-06	3.04e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GPX1—coronary artery disease	2.14e-06	3.03e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CA—coronary artery disease	2.14e-06	3.02e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.12e-06	3.01e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LPA—coronary artery disease	2.1e-06	2.97e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GOT1—coronary artery disease	2.09e-06	2.96e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GGT1—coronary artery disease	2.09e-06	2.96e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CD36—coronary artery disease	2.08e-06	2.95e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—AKT1—coronary artery disease	2.07e-06	2.93e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPP2CA—coronary artery disease	2.06e-06	2.91e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PLCB1—coronary artery disease	2.05e-06	2.9e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.03e-06	2.88e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.03e-06	2.87e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOA5—coronary artery disease	2.01e-06	2.85e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.99e-06	2.82e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—AKT1—coronary artery disease	1.98e-06	2.81e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCA1—coronary artery disease	1.98e-06	2.81e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MTHFR—coronary artery disease	1.97e-06	2.8e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—P4HB—coronary artery disease	1.97e-06	2.79e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.97e-06	2.78e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.94e-06	2.74e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GOT1—coronary artery disease	1.92e-06	2.72e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GGT1—coronary artery disease	1.92e-06	2.72e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GGT1—coronary artery disease	1.9e-06	2.7e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GOT1—coronary artery disease	1.9e-06	2.7e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AGT—coronary artery disease	1.88e-06	2.66e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTP1—coronary artery disease	1.88e-06	2.66e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	1.86e-06	2.63e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMOX1—coronary artery disease	1.85e-06	2.62e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APOE—coronary artery disease	1.84e-06	2.6e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—VCAN—coronary artery disease	1.83e-06	2.59e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CAT—coronary artery disease	1.83e-06	2.58e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APOA1—coronary artery disease	1.82e-06	2.57e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.81e-06	2.57e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOB—coronary artery disease	1.77e-06	2.51e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—DCN—coronary artery disease	1.76e-06	2.49e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—AKT1—coronary artery disease	1.74e-06	2.47e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.73e-06	2.44e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTM1—coronary artery disease	1.72e-06	2.44e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.71e-06	2.42e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.71e-06	2.42e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.71e-06	2.42e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.7e-06	2.41e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.69e-06	2.4e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—LPL—coronary artery disease	1.69e-06	2.4e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.69e-06	2.39e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CAT—coronary artery disease	1.68e-06	2.38e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HBA1—coronary artery disease	1.67e-06	2.36e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LIPC—coronary artery disease	1.67e-06	2.36e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.67e-06	2.36e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.67e-06	2.36e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CAT—coronary artery disease	1.66e-06	2.36e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOC3—coronary artery disease	1.66e-06	2.35e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GPX1—coronary artery disease	1.65e-06	2.34e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LDLR—coronary artery disease	1.65e-06	2.33e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOB—coronary artery disease	1.63e-06	2.31e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.63e-06	2.3e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.63e-06	2.3e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOB—coronary artery disease	1.62e-06	2.29e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GCLC—coronary artery disease	1.61e-06	2.28e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CETP—coronary artery disease	1.61e-06	2.28e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CD36—coronary artery disease	1.61e-06	2.28e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPARG—coronary artery disease	1.6e-06	2.27e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SDC1—coronary artery disease	1.59e-06	2.25e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPP2CA—coronary artery disease	1.59e-06	2.25e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.59e-06	2.25e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—POMC—coronary artery disease	1.58e-06	2.24e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.57e-06	2.23e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—LPL—coronary artery disease	1.56e-06	2.2e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—LPL—coronary artery disease	1.54e-06	2.18e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.52e-06	2.16e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GPX1—coronary artery disease	1.52e-06	2.15e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GPX1—coronary artery disease	1.51e-06	2.13e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.5e-06	2.13e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.5e-06	2.13e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CD36—coronary artery disease	1.48e-06	2.09e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CTGF—coronary artery disease	1.47e-06	2.08e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CD36—coronary artery disease	1.47e-06	2.08e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.46e-06	2.07e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.45e-06	2.06e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GOT2—coronary artery disease	1.45e-06	2.06e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.45e-06	2.05e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AGT—coronary artery disease	1.45e-06	2.05e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALB—coronary artery disease	1.44e-06	2.04e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOE—coronary artery disease	1.42e-06	2.01e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOA1—coronary artery disease	1.4e-06	1.99e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.4e-06	1.98e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.39e-06	1.97e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NOS3—coronary artery disease	1.38e-06	1.95e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.34e-06	1.9e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.34e-06	1.89e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AGT—coronary artery disease	1.33e-06	1.89e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AGT—coronary artery disease	1.32e-06	1.87e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOE—coronary artery disease	1.3e-06	1.85e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.3e-06	1.84e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOE—coronary artery disease	1.29e-06	1.83e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOA1—coronary artery disease	1.29e-06	1.83e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOA1—coronary artery disease	1.28e-06	1.81e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS2—coronary artery disease	1.26e-06	1.78e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GGT1—coronary artery disease	1.26e-06	1.78e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GOT1—coronary artery disease	1.26e-06	1.78e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPARG—coronary artery disease	1.24e-06	1.75e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.22e-06	1.73e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—POMC—coronary artery disease	1.22e-06	1.73e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPARG—coronary artery disease	1.14e-06	1.61e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.13e-06	1.6e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPARG—coronary artery disease	1.13e-06	1.6e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—POMC—coronary artery disease	1.12e-06	1.59e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.12e-06	1.58e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.11e-06	1.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—POMC—coronary artery disease	1.11e-06	1.57e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALB—coronary artery disease	1.11e-06	1.57e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CAT—coronary artery disease	1.1e-06	1.55e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOB—coronary artery disease	1.07e-06	1.51e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NOS3—coronary artery disease	1.06e-06	1.5e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.04e-06	1.47e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALB—coronary artery disease	1.02e-06	1.45e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LPL—coronary artery disease	1.02e-06	1.44e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALB—coronary artery disease	1.01e-06	1.43e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPX1—coronary artery disease	9.93e-07	1.41e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NOS3—coronary artery disease	9.77e-07	1.38e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS2—coronary artery disease	9.72e-07	1.38e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NOS3—coronary artery disease	9.69e-07	1.37e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CD36—coronary artery disease	9.67e-07	1.37e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	9.55e-07	1.35e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTHFR—coronary artery disease	9.16e-07	1.3e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS2—coronary artery disease	8.94e-07	1.27e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS2—coronary artery disease	8.86e-07	1.25e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AGT—coronary artery disease	8.7e-07	1.23e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOE—coronary artery disease	8.53e-07	1.21e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOA1—coronary artery disease	8.43e-07	1.19e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CA—coronary artery disease	7.75e-07	1.1e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARG—coronary artery disease	7.43e-07	1.05e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—POMC—coronary artery disease	7.33e-07	1.04e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALB—coronary artery disease	6.68e-07	9.46e-06	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NOS3—coronary artery disease	6.39e-07	9.05e-06	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKT1—coronary artery disease	6.33e-07	8.97e-06	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CA—coronary artery disease	5.98e-07	8.47e-06	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS2—coronary artery disease	5.84e-07	8.28e-06	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CA—coronary artery disease	5.5e-07	7.79e-06	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CA—coronary artery disease	5.45e-07	7.72e-06	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKT1—coronary artery disease	4.88e-07	6.92e-06	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKT1—coronary artery disease	4.49e-07	6.36e-06	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKT1—coronary artery disease	4.45e-07	6.31e-06	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.6e-07	5.09e-06	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKT1—coronary artery disease	2.94e-07	4.16e-06	CbGpPWpGaD
